Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Healthtrust
Accenture
Mallinckrodt
Cerilliant
UBS
Harvard Business School
AstraZeneca

Generated: April 26, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: cysteamine bitartrate

« Back to Dashboard

cysteamine bitartrate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Horizon Pharma Usa PROCYSBI cysteamine bitartrate CAPSULE, DELAYED RELEASE;ORAL 203389 NDA Raptor Therapeutics Inc. N 49663-001-06
Horizon Pharma Usa PROCYSBI cysteamine bitartrate CAPSULE, DELAYED RELEASE;ORAL 203389 NDA Raptor Therapeutics Inc. N 49663-002-25
Horizon Pharma Usa PROCYSBI cysteamine bitartrate CAPSULE, DELAYED RELEASE;ORAL 203389 NDA Horizon Pharma Inc. N 75987-100-04
Horizon Pharma Usa PROCYSBI cysteamine bitartrate CAPSULE, DELAYED RELEASE;ORAL 203389 NDA Horizon Pharma Inc. N 75987-101-08
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
McKinsey
McKesson
Farmers Insurance
Colorcon
Cantor Fitzgerald
Dow
Argus Health